Carlos Martín‐de Vicente, Maria Carmen Luna‐Paredes, Isabel Delgado‐Pecellín, M. Dolores Pastor‐Vivero, Estela Pérez‐Ruiz. Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis and N1303K Variant: Experience in a Pediatric Cohort. // Pediatric Pulmonology. – 2026. – DOI: 10.1002/ppul.71911. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ppul.71911?af=R
Carlos Martín‐de Vicente, Maria Carmen Luna‐Paredes, Isabel Delgado‐Pecellín, M. Dolores Pastor‐Vivero, & Estela Pérez‐Ruiz (2026). Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis and N1303K Variant: Experience in a Pediatric Cohort. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71911
Carlos Martín‐de Vicente, et al. “Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis and N1303K Variant: Experience in a Pediatric Cohort.” Pediatric Pulmonology, 2026. doi:10.1002/ppul.71911.
@article{Vicente2026,
title = {Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis and N1303K Variant: Experience in a Pediatric Cohort},
author = {Vicente, Carlos Martín‐de and Luna‐Paredes, Maria Carmen and Delgado‐Pecellín, Isabel and Pastor‐Vivero, M. Dolores and Pérez‐Ruiz, Estela},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71911},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ppul.71911?af=R}
}